IntegraGen SA

As of June 30, 2024, IntegraGen SA carries a market capitalization of 3.51M, placing it among publicly traded companies globally. Its enterprise value stands at 2.47M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

IntegraGen SA's next confirmed earnings release is scheduled for April 28, 2027.

As of June 30, 2024, IntegraGen SA has 6.62M shares outstanding.

These figures are as of June 30, 2024.

As of June 30, 2024, IntegraGen SA maintains a current ratio of 1.54, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2024.

As of the close on October 22, 2026, IntegraGen SA's stock has declined approximately 54.10% over the past 52 weeks. The 50-day moving average sits at 0.12, while the 200-day moving average is 0.16.

As of June 30, 2024, IntegraGen SA holds 1.91M in cash and equivalents against 869,023.00 in total debt, resulting in a net debt position of 7,235.00. Total book value stands at 1.90M, with working capital of 2.10M providing operational flexibility.